BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180604
DTEND;VALUE=DATE:20180607
DTSTAMP:20260730T042009
CREATED:20180506T082708Z
LAST-MODIFIED:20180506T084727Z
UID:20022-1528070400-1528329599@ces.b2sg.org
SUMMARY:Molecular Pathology Approach to Cancer
DESCRIPTION:Molecular pathology is one of the linchpins of precision medicine. No longer can treatment decisions related to therapy selection be rendered solely on the basis of histopathological analyses\, as genomic analyses of human cancers are resulting in the identification of the genetic determinants of tumourigenesis\, cancer progression and therapy response. \nThe pathologists’ role in the implementation of molecular tests in diagnostic practice and the ability of pathology laboratories to perform these tests and communicate the results to oncologists are germane to the successful translation of scientific advancements into benefit to patients. \nThis course aims to provide a comprehensive overview of the state-of-the-art molecular pathology approaches and their application\, and to discuss current genomics and molecular pathology of solid malignancies. \nTarget audience\nThis course will provide a discussion of current concepts in molecular pathology\, molecular pathology methods and their application. It will be beneficial for practicing pathologists and oncologists\, residents and fellows in pathology and oncology\, and molecular biologists with an interest in molecular pathology and precision medicine. \nTopics to be covered\n\nThe role of the pathologist in precision medicine\nMassively parallel sequencing methods and data interpretation\nGene expression regulation\nPlasma circulating cell-free DNA analysis\nPerspectives in molecular testing for clinical decision-making in oncology in Europe and USA\nThe molecular pathology of immunotherapy response\nMolecular pathology of breast cancer and the usefulness of transcriptomic and genomic biomarkers in breast cancer pathology and oncology practice\nNovel findings in ovarian and endometrial cancers\nTargeted therapies in melanoma\nKIT and novel therapeutic targets in gastrointestinal stromal tumours\nGenomics of lung and colorectal cancers\, and the use of genetic biomarkers for therapeutic decision-making\nMolecular classification of sarcomas and central nervous system tumours\n\nKey dates\nBursary application deadline:\n 06 April 2018 \nRegistration deadline:\n 04 May 2018
URL:https://ces.b2sg.org/event/eacr-4jun18/
LOCATION:De Rode Hoed\, Keizersgracht 102\, Amsterdam\, 1015\, Netherlands
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/EACR-new-logo-jpeg-e1526380502516.jpg
ORGANIZER;CN="Laura%20Strachan%20%28Conference%20and%20Ambassador%20Officer%29":MAILTO:l.strachan@nottingham.ac.uk
END:VEVENT
END:VCALENDAR